HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATION

Clinical trials for HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATION trials appear

Sign up with your email to follow new studies for HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug shows promise for Hard-to-Treat cancers with specific gene changes

Disease control Completed

This study tested an experimental drug called IDX-1197 in 108 adults with solid tumors that have a specific gene mutation (HRR). Participants had already tried standard treatments without success. The goal was to find the safest and most effective dose and see if the drug could s…

Matched conditions: HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATION

Phase: PHASE1, PHASE2 • Sponsor: Idience Co., Ltd. • Aim: Disease control

Last updated May 13, 2026 15:58 UTC

HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATION

Get alerted when new HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATION trials appear

New drug shows promise for Hard-to-Treat cancers with specific gene changes